BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Halozyme Picks Up Antares’ Drug Delivery Tech for Nearly $1B

  Halozyme Therapeutics announced that it is acquiring Antares Pharma for $960 million in cash. The news caused Antares stock to rocket 47% in premarket trading.

  April 13, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Legal Fees for Shkreli, Holmes, Purdue Go Unpaid as Cases Unfold

  As Martin Shkreli, Elizabeth Holmes and Sunny Balwani, and the Purdue bankruptcy deal play out, there is even more drama beyond the stories–a failure to pay legal fees.

  April 13, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  AbbVie, Others Spring Into New Real Estate, Personnel Investments

  With Spring comes new beginnings, and companies within the biopharmaceutical industry are blossoming with fresh ventures. Here are some of them:

  April 13, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano
• 

  Drug Development

  Study Calls into Question Link Between COVID-19 Vaccines and Myopericarditis

  Reports that myopericarditis may be a side effect of COVID-19 vaccination are downplayed by a recently published study that suggests there might not be a correlation.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Business

  Money on the Move: April 6-13

  Companies working on cell therapies got most of the funding in the life sciences venture capital world this week. For that and more, continue reading.

  April 13, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  Global Roundup: A CAR-T Partnership and CDR-Life Nabs $76M to Engage Solid Tumors

  Australia’s Chimeric Therapeutics has partnered with WuXi ATU on two autologous CAR T-cell therapies for solid tumors. Switzerland-based CDR-Life closed a $76 million Series A.

  April 13, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Deals

  GSK Acquires Sierra in $1.9B Complimentary Deal Aimed at Rare Cancers

  GSK is acquiring Sierra Oncology for $1.9 billion in a deal expected to help both companies take a major step in developing a treatment for rare types of cancer.

  April 13, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  AACR Spotlight: Victoria’s Secret Awards 5 Female Cancer Researchers, AbbVie and More

  As the American Association of Cancer Research (AACR) Annual Meeting wraps up, there were some surprising and exciting research news and presentations.

  April 13, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  ProQR to Cut 30% of Workforce, CSO Following Unexpected Trial Failure

  ProQR Therapeutics, which is developing RNA therapies for genetic eye diseases, announced Wednesday that it will be restructuring and laying off 30% of its staff.

  April 13, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  9 Meters Scores Patent for Hyperphagia, Obesity-Fighting Drug

  9 Meters Biopharma has received notice from the U.S. Patent and Trademark Office (USPTO) allowing its patent for therapeutic NM-136 to treat hyperphagia (extreme hunger) and obesity.

  April 13, 2022

   · 

  3 min read

   · 

  Hayley Shasteen